4-Hydroxytamoxifen
SIAL/94873 - (E) and (Z) isomers (50:50), analytical standard
Synonym: 4-
CAS Number: 68392-35-8
Empirical Formula (Hill Notation): C26H29NO2
Molecular Weight: 387.51
Linear Formula: C26H29NO2
Product Type: Chemical
application(s) | forensics and toxicology pharmaceutical (small molecule) |
assay | ≥97.5% (HPLC) |
format | neat |
grade | analytical standard |
impurities | ≤5.0% water |
InChI | 1S/2C26H29NO2/c2*1-4-25(2 |
InChI key | ZJLDABGSDWXVGE-BDSXMVAQSA |
Quality Level | 100 |
shelf life | limited shelf life, expiry date on the label |
SMILES string | CCC(c1ccccc1)=C(/c2ccc(O |
technique(s) | gas chromatography (GC): suitable |
HPLC: suitable |
Application: | 4-Hydroxytamoxifen may be used as a reference standard in the determination of 4-hydroxythmoxifen in plasma samples using high-performance liquid chromatography with fluorescence detection (HPLC). |
Application: | Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support. |
Biochem/physiol Actions: | Metabolite of the chemotherapeutic drug tamoxifen, exhibiting more potent estrogen agonist/antagonist activity than the parent drug. Also active as intra-membranous inhibitor of lipid peroxidation. |
General description: | 4-Hydroxytamoxifen is a first generation, selective estrogen receptor modulator (SERM) that functions as an antagonist in breast cancer cells but can display estrogen-like activities in the uterus and bone. |
Symbol | GHS07,GHS08 |
Signal word | Warning |
Hazard statements | H302 + H312 + H332 - H361 |
Precautionary statements | P201 - P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 - P308 + P313 |
Hazard Codes | Xn |
Risk Statements | 63-20/21/22 |
Safety Statements | 22-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥97.5% (HPLC) |
UNSPSC | 41116107 |